No evidence yet that it’s time for a 3rd booster, says former FDA director_老虎社区_美港股上老虎

No evidence yet that it’s time for a 3rd booster, says former FDA director

cnbc2021-07-16

KEY POINTS There’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting. “We’re just not there yet … we don’...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

babyshark
·2021-07-16
Great
回复
1
举报
hui1234567
·2021-07-16
awesome
回复
2
举报
jefftt
·2021-07-16
great
回复
点赞
举报
HEYEOH
·2021-07-16
Great
回复
点赞
举报
erichosk
·2021-07-16
The us his doesn't want to admit that its vaccines are ineffective. The US still proclaims that breakthrough cases are rare when we see them everyday.
回复
1
举报
收起
- TeslaLegend:
  Nice
  2021-07-16
  回复
  举报
- erichosk:
  yup
  2021-07-17
  回复
  举报
Jiaenthebest
·2021-07-16
Great
回复
2
举报
收起
- Jiaenthebest:
  Wow
  2021-07-16
  回复
  举报
Never ever f
·2021-07-16
Power booster
回复
1
举报
Rdzx93
·2021-07-16
Like and comment
回复
5
举报
收起
- Rdzx93:
  Like and comment
  2021-07-16
  回复
  举报
- Rdzx93:
  Like and comment
  2021-07-16
  回复
  举报
- Rdzx93回复Rdzx93:
  Like and comment
  2021-07-16
  回复
  举报
查看更多 2 条评论
Avester
·2021-07-16
Comment
回复
1
举报
收起
- Sallkwan:
  Great
  2021-09-16
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1176367685?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-07-16 13:19","share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","id":"1176367685","market":"us","top_or_hot":-1,"title":"No evidence yet that it’s time for a 3rd booster, says former FDA director","media":"cnbc","content":"<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">网页链接</a>\n\n</div>\n","source":"cnbc_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>No evidence yet that it’s time for a 3rd booster, says former FDA director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNo evidence yet that it’s time for a 3rd booster, says former FDA director\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 13:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNTX","symbol_name":"BioNTech SE","start_time":0,"source_url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","article_id":"1176367685","we_media_id":null,"thumbnails":[],"rights":{"source":"cnbc_highlight","url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.ArticleHeader-headline{#titleStyle#}a{#lv2TextColor#}.ArticleHeader-time, .Author-authorNameAndSocial a{#sourceStyle#;}","selectors":".PageBuilder-pageWrapper","filters":".ArticleHeader-eyebrow, .RelatedTags-relatedTags","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1176367685","pubTimestamp":1626412781,"sourceInfo":{"source_id":"cnbc_highlight","name":"CNBC"},"weMediaInfo":null,"summary":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor","collect":0,"end_time":0,"defaultTopTitle":"cnbc.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"translate_title":"前美国食品和药物管理局局长说，还没有证据表明是时候进行第三次增强剂了","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.9,"PFE":0.9},"content_text":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nPfizer said on July 8 that it is developing a Covid booster shot, or third dose, to target the highly transmissible delta variant.\n\nThere isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director.\n“Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review.\nPharmaceutical firm Pfizerisdeveloping a Covid booster shot, or third dose, to target the highly transmissible delta variant,which has become the dominant strain in many countries including the U.S.\nThe Centers for Disease Control and Prevention and FDA also said last week in a joint statement that“Americans who have been fully vaccinated won’t need a booster dose at this time.”\nPfizer met with U.S. officials on Mondayto make its case for a third shot.\nThe company worked with German companyBioNTechto develop a vaccine that consists of two doses given three weeks apart. It was given emergency use authorization by the World Health Organization in December.\nNo significant vaccine failure\nPfizer and BioNTech pointed to data fromIsrael’s health ministry that said there was decreased effectiveness in their vaccine,in terms of preventing infection and symptomatic disease.\nThe decline in efficacy coincided with the spread of the delta variant and the end of most Covid measures in Israel. The shot remains 93% effective in preventing hospitalizations and serious illness from Covid-19, the ministry reportedly said.\n\n The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose.Norman BaylorBIOLOGICS CONSULTING CEO\n\nBut Baylor, who is currently president and chief executive officer of Biologics Consulting, said close monitoring has not revealed “significant vaccine failures” so far.\n“We’re just not seeing that now,” he told“Street Signs Asia”on Thursday.\nCovid cases are rising in the U.S. again, butdoctors say the increase in cases and hospitalizations are due to the delta variant spreading in unvaccinated populations.\n“The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose,” Baylor said.\nHe said health agencies seem to be in agreement that a third dose is not needed.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nVaccine inequality\nRicher countries have been able to vaccinate large numbers of their population, while poorer countries lag behind.\nThe issue of vaccine disparity between regions needs to be addressed, Baylor said.\n“A pandemic itself, the definition is that it’s global,” he said, adding that he agrees with the World Health Organization that the crisis needs to be looked at from a global perspective.\n\n Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable.Tedros Adhanom GhebreyesusDIRECTOR-GENERAL, WORLD HEALTH ORGANIZATION\n\nWHO Director-General Tedros Adhanom Ghebreyesus said Monday thatthe world is “in the midst of a growing two-track pandemic.”\n“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable,”he said during a press briefing, adding that the world ismaking “conscious choices” not to protect those who are most in need.\nData suggests the vaccines offer long-lasting immunity against severe and deadly Covid-19, he said.\n“The priority now must be to vaccinate those who have received no doses and protection,” the WHO chief said.\nBiotech companies like Pfizer-BioNTech andModerna, which developed another mRNA vaccine for Covid-19, need to “go all out” to channel supplies to places in need, including through the Covax vaccine distribution alliance, he added.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":170254749,"gmtCreate":1626438825981,"gmtModify":1633926764220,"author":{"id":"3572656728096523","authorId":"3572656728096523","name":"babyshark","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3572656728096523","authorIdStr":"3572656728096523"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170254749","repostId":1176367685,"repostType":4,"repost":{"id":"1176367685","pubTimestamp":1626412781,"share":"https://www.laohu8.com/m/news/1176367685?lang=&edition=full","pubTime":"2021-07-16 13:19","market":"us","language":"en","title":"No evidence yet that it’s time for a 3rd booster, says former FDA director","url":"https://stock-news.laohu8.com/highlight/detail?id=1176367685","media":"cnbc","summary":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor","content":"<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>No evidence yet that it’s time for a 3rd booster, says former FDA director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNo evidence yet that it’s time for a 3rd booster, says former FDA director\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 13:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1176367685","content_text":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nPfizer said on July 8 that it is developing a Covid booster shot, or third dose, to target the highly transmissible delta variant.\n\nThere isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director.\n“Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review.\nPharmaceutical firm Pfizerisdeveloping a Covid booster shot, or third dose, to target the highly transmissible delta variant,which has become the dominant strain in many countries including the U.S.\nThe Centers for Disease Control and Prevention and FDA also said last week in a joint statement that“Americans who have been fully vaccinated won’t need a booster dose at this time.”\nPfizer met with U.S. officials on Mondayto make its case for a third shot.\nThe company worked with German companyBioNTechto develop a vaccine that consists of two doses given three weeks apart. It was given emergency use authorization by the World Health Organization in December.\nNo significant vaccine failure\nPfizer and BioNTech pointed to data fromIsrael’s health ministry that said there was decreased effectiveness in their vaccine,in terms of preventing infection and symptomatic disease.\nThe decline in efficacy coincided with the spread of the delta variant and the end of most Covid measures in Israel. The shot remains 93% effective in preventing hospitalizations and serious illness from Covid-19, the ministry reportedly said.\n\n The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose.Norman BaylorBIOLOGICS CONSULTING CEO\n\nBut Baylor, who is currently president and chief executive officer of Biologics Consulting, said close monitoring has not revealed “significant vaccine failures” so far.\n“We’re just not seeing that now,” he told“Street Signs Asia”on Thursday.\nCovid cases are rising in the U.S. again, butdoctors say the increase in cases and hospitalizations are due to the delta variant spreading in unvaccinated populations.\n“The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose,” Baylor said.\nHe said health agencies seem to be in agreement that a third dose is not needed.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nVaccine inequality\nRicher countries have been able to vaccinate large numbers of their population, while poorer countries lag behind.\nThe issue of vaccine disparity between regions needs to be addressed, Baylor said.\n“A pandemic itself, the definition is that it’s global,” he said, adding that he agrees with the World Health Organization that the crisis needs to be looked at from a global perspective.\n\n Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable.Tedros Adhanom GhebreyesusDIRECTOR-GENERAL, WORLD HEALTH ORGANIZATION\n\nWHO Director-General Tedros Adhanom Ghebreyesus said Monday thatthe world is “in the midst of a growing two-track pandemic.”\n“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable,”he said during a press briefing, adding that the world ismaking “conscious choices” not to protect those who are most in need.\nData suggests the vaccines offer long-lasting immunity against severe and deadly Covid-19, he said.\n“The priority now must be to vaccinate those who have received no doses and protection,” the WHO chief said.\nBiotech companies like Pfizer-BioNTech andModerna, which developed another mRNA vaccine for Covid-19, need to “go all out” to channel supplies to places in need, including through the Covax vaccine distribution alliance, he added.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":170804527,"gmtCreate":1626417218369,"gmtModify":1631890242008,"author":{"id":"4087899267516000","authorId":"4087899267516000","name":"hui1234567","avatar":"https://static.tigerbbs.com/f1ef5eb26f8ef01d38bcf417264003a1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087899267516000","authorIdStr":"4087899267516000"},"htmlText":"awesome&nbsp;","listText":"awesome&nbsp;","text":"awesome","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170804527","repostId":1176367685,"repostType":4,"repost":{"id":"1176367685","pubTimestamp":1626412781,"share":"https://www.laohu8.com/m/news/1176367685?lang=&edition=full","pubTime":"2021-07-16 13:19","market":"us","language":"en","title":"No evidence yet that it’s time for a 3rd booster, says former FDA director","url":"https://stock-news.laohu8.com/highlight/detail?id=1176367685","media":"cnbc","summary":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor","content":"<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>No evidence yet that it’s time for a 3rd booster, says former FDA director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNo evidence yet that it’s time for a 3rd booster, says former FDA director\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 13:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1176367685","content_text":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nPfizer said on July 8 that it is developing a Covid booster shot, or third dose, to target the highly transmissible delta variant.\n\nThere isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director.\n“Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review.\nPharmaceutical firm Pfizerisdeveloping a Covid booster shot, or third dose, to target the highly transmissible delta variant,which has become the dominant strain in many countries including the U.S.\nThe Centers for Disease Control and Prevention and FDA also said last week in a joint statement that“Americans who have been fully vaccinated won’t need a booster dose at this time.”\nPfizer met with U.S. officials on Mondayto make its case for a third shot.\nThe company worked with German companyBioNTechto develop a vaccine that consists of two doses given three weeks apart. It was given emergency use authorization by the World Health Organization in December.\nNo significant vaccine failure\nPfizer and BioNTech pointed to data fromIsrael’s health ministry that said there was decreased effectiveness in their vaccine,in terms of preventing infection and symptomatic disease.\nThe decline in efficacy coincided with the spread of the delta variant and the end of most Covid measures in Israel. The shot remains 93% effective in preventing hospitalizations and serious illness from Covid-19, the ministry reportedly said.\n\n The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose.Norman BaylorBIOLOGICS CONSULTING CEO\n\nBut Baylor, who is currently president and chief executive officer of Biologics Consulting, said close monitoring has not revealed “significant vaccine failures” so far.\n“We’re just not seeing that now,” he told“Street Signs Asia”on Thursday.\nCovid cases are rising in the U.S. again, butdoctors say the increase in cases and hospitalizations are due to the delta variant spreading in unvaccinated populations.\n“The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose,” Baylor said.\nHe said health agencies seem to be in agreement that a third dose is not needed.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nVaccine inequality\nRicher countries have been able to vaccinate large numbers of their population, while poorer countries lag behind.\nThe issue of vaccine disparity between regions needs to be addressed, Baylor said.\n“A pandemic itself, the definition is that it’s global,” he said, adding that he agrees with the World Health Organization that the crisis needs to be looked at from a global perspective.\n\n Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable.Tedros Adhanom GhebreyesusDIRECTOR-GENERAL, WORLD HEALTH ORGANIZATION\n\nWHO Director-General Tedros Adhanom Ghebreyesus said Monday thatthe world is “in the midst of a growing two-track pandemic.”\n“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable,”he said during a press briefing, adding that the world ismaking “conscious choices” not to protect those who are most in need.\nData suggests the vaccines offer long-lasting immunity against severe and deadly Covid-19, he said.\n“The priority now must be to vaccinate those who have received no doses and protection,” the WHO chief said.\nBiotech companies like Pfizer-BioNTech andModerna, which developed another mRNA vaccine for Covid-19, need to “go all out” to channel supplies to places in need, including through the Covax vaccine distribution alliance, he added.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":170809735,"gmtCreate":1626416643927,"gmtModify":1633926926862,"author":{"id":"3583057062119819","authorId":"3583057062119819","name":"jefftt","avatar":"https://static.tigerbbs.com/6bd621880c70630553bf57418e846287","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583057062119819","authorIdStr":"3583057062119819"},"htmlText":"great","listText":"great","text":"great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170809735","repostId":1176367685,"repostType":4,"repost":{"id":"1176367685","pubTimestamp":1626412781,"share":"https://www.laohu8.com/m/news/1176367685?lang=&edition=full","pubTime":"2021-07-16 13:19","market":"us","language":"en","title":"No evidence yet that it’s time for a 3rd booster, says former FDA director","url":"https://stock-news.laohu8.com/highlight/detail?id=1176367685","media":"cnbc","summary":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor","content":"<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>No evidence yet that it’s time for a 3rd booster, says former FDA director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNo evidence yet that it’s time for a 3rd booster, says former FDA director\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 13:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1176367685","content_text":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nPfizer said on July 8 that it is developing a Covid booster shot, or third dose, to target the highly transmissible delta variant.\n\nThere isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director.\n“Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review.\nPharmaceutical firm Pfizerisdeveloping a Covid booster shot, or third dose, to target the highly transmissible delta variant,which has become the dominant strain in many countries including the U.S.\nThe Centers for Disease Control and Prevention and FDA also said last week in a joint statement that“Americans who have been fully vaccinated won’t need a booster dose at this time.”\nPfizer met with U.S. officials on Mondayto make its case for a third shot.\nThe company worked with German companyBioNTechto develop a vaccine that consists of two doses given three weeks apart. It was given emergency use authorization by the World Health Organization in December.\nNo significant vaccine failure\nPfizer and BioNTech pointed to data fromIsrael’s health ministry that said there was decreased effectiveness in their vaccine,in terms of preventing infection and symptomatic disease.\nThe decline in efficacy coincided with the spread of the delta variant and the end of most Covid measures in Israel. The shot remains 93% effective in preventing hospitalizations and serious illness from Covid-19, the ministry reportedly said.\n\n The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose.Norman BaylorBIOLOGICS CONSULTING CEO\n\nBut Baylor, who is currently president and chief executive officer of Biologics Consulting, said close monitoring has not revealed “significant vaccine failures” so far.\n“We’re just not seeing that now,” he told“Street Signs Asia”on Thursday.\nCovid cases are rising in the U.S. again, butdoctors say the increase in cases and hospitalizations are due to the delta variant spreading in unvaccinated populations.\n“The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose,” Baylor said.\nHe said health agencies seem to be in agreement that a third dose is not needed.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nVaccine inequality\nRicher countries have been able to vaccinate large numbers of their population, while poorer countries lag behind.\nThe issue of vaccine disparity between regions needs to be addressed, Baylor said.\n“A pandemic itself, the definition is that it’s global,” he said, adding that he agrees with the World Health Organization that the crisis needs to be looked at from a global perspective.\n\n Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable.Tedros Adhanom GhebreyesusDIRECTOR-GENERAL, WORLD HEALTH ORGANIZATION\n\nWHO Director-General Tedros Adhanom Ghebreyesus said Monday thatthe world is “in the midst of a growing two-track pandemic.”\n“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable,”he said during a press briefing, adding that the world ismaking “conscious choices” not to protect those who are most in need.\nData suggests the vaccines offer long-lasting immunity against severe and deadly Covid-19, he said.\n“The priority now must be to vaccinate those who have received no doses and protection,” the WHO chief said.\nBiotech companies like Pfizer-BioNTech andModerna, which developed another mRNA vaccine for Covid-19, need to “go all out” to channel supplies to places in need, including through the Covax vaccine distribution alliance, he added.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":170171421,"gmtCreate":1626416077663,"gmtModify":1633926931966,"author":{"id":"3582007328932461","authorId":"3582007328932461","name":"HEYEOH","avatar":"https://static.tigerbbs.com/c45d4be430134ef68c1a287611337dd4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582007328932461","authorIdStr":"3582007328932461"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170171421","repostId":1176367685,"repostType":4,"repost":{"id":"1176367685","pubTimestamp":1626412781,"share":"https://www.laohu8.com/m/news/1176367685?lang=&edition=full","pubTime":"2021-07-16 13:19","market":"us","language":"en","title":"No evidence yet that it’s time for a 3rd booster, says former FDA director","url":"https://stock-news.laohu8.com/highlight/detail?id=1176367685","media":"cnbc","summary":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor","content":"<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>No evidence yet that it’s time for a 3rd booster, says former FDA director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNo evidence yet that it’s time for a 3rd booster, says former FDA director\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 13:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1176367685","content_text":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nPfizer said on July 8 that it is developing a Covid booster shot, or third dose, to target the highly transmissible delta variant.\n\nThere isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director.\n“Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review.\nPharmaceutical firm Pfizerisdeveloping a Covid booster shot, or third dose, to target the highly transmissible delta variant,which has become the dominant strain in many countries including the U.S.\nThe Centers for Disease Control and Prevention and FDA also said last week in a joint statement that“Americans who have been fully vaccinated won’t need a booster dose at this time.”\nPfizer met with U.S. officials on Mondayto make its case for a third shot.\nThe company worked with German companyBioNTechto develop a vaccine that consists of two doses given three weeks apart. It was given emergency use authorization by the World Health Organization in December.\nNo significant vaccine failure\nPfizer and BioNTech pointed to data fromIsrael’s health ministry that said there was decreased effectiveness in their vaccine,in terms of preventing infection and symptomatic disease.\nThe decline in efficacy coincided with the spread of the delta variant and the end of most Covid measures in Israel. The shot remains 93% effective in preventing hospitalizations and serious illness from Covid-19, the ministry reportedly said.\n\n The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose.Norman BaylorBIOLOGICS CONSULTING CEO\n\nBut Baylor, who is currently president and chief executive officer of Biologics Consulting, said close monitoring has not revealed “significant vaccine failures” so far.\n“We’re just not seeing that now,” he told“Street Signs Asia”on Thursday.\nCovid cases are rising in the U.S. again, butdoctors say the increase in cases and hospitalizations are due to the delta variant spreading in unvaccinated populations.\n“The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose,” Baylor said.\nHe said health agencies seem to be in agreement that a third dose is not needed.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nVaccine inequality\nRicher countries have been able to vaccinate large numbers of their population, while poorer countries lag behind.\nThe issue of vaccine disparity between regions needs to be addressed, Baylor said.\n“A pandemic itself, the definition is that it’s global,” he said, adding that he agrees with the World Health Organization that the crisis needs to be looked at from a global perspective.\n\n Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable.Tedros Adhanom GhebreyesusDIRECTOR-GENERAL, WORLD HEALTH ORGANIZATION\n\nWHO Director-General Tedros Adhanom Ghebreyesus said Monday thatthe world is “in the midst of a growing two-track pandemic.”\n“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable,”he said during a press briefing, adding that the world ismaking “conscious choices” not to protect those who are most in need.\nData suggests the vaccines offer long-lasting immunity against severe and deadly Covid-19, he said.\n“The priority now must be to vaccinate those who have received no doses and protection,” the WHO chief said.\nBiotech companies like Pfizer-BioNTech andModerna, which developed another mRNA vaccine for Covid-19, need to “go all out” to channel supplies to places in need, including through the Covax vaccine distribution alliance, he added.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":170144266,"gmtCreate":1626415745555,"gmtModify":1633926934978,"author":{"id":"3575433293784452","authorId":"3575433293784452","name":"erichosk","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3575433293784452","authorIdStr":"3575433293784452"},"htmlText":"The us his doesn't want to admit that its vaccines are ineffective.&nbsp; The US still proclaims that breakthrough cases are rare when we see them everyday.","listText":"The us his doesn't want to admit that its vaccines are ineffective.&nbsp; The US still proclaims that breakthrough cases are rare when we see them everyday.","text":"The us his doesn't want to admit that its vaccines are ineffective. The US still proclaims that breakthrough cases are rare when we see them everyday.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/170144266","repostId":1176367685,"repostType":4,"repost":{"id":"1176367685","pubTimestamp":1626412781,"share":"https://www.laohu8.com/m/news/1176367685?lang=&edition=full","pubTime":"2021-07-16 13:19","market":"us","language":"en","title":"No evidence yet that it’s time for a 3rd booster, says former FDA director","url":"https://stock-news.laohu8.com/highlight/detail?id=1176367685","media":"cnbc","summary":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor","content":"<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>No evidence yet that it’s time for a 3rd booster, says former FDA director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNo evidence yet that it’s time for a 3rd booster, says former FDA director\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 13:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1176367685","content_text":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nPfizer said on July 8 that it is developing a Covid booster shot, or third dose, to target the highly transmissible delta variant.\n\nThere isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director.\n“Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review.\nPharmaceutical firm Pfizerisdeveloping a Covid booster shot, or third dose, to target the highly transmissible delta variant,which has become the dominant strain in many countries including the U.S.\nThe Centers for Disease Control and Prevention and FDA also said last week in a joint statement that“Americans who have been fully vaccinated won’t need a booster dose at this time.”\nPfizer met with U.S. officials on Mondayto make its case for a third shot.\nThe company worked with German companyBioNTechto develop a vaccine that consists of two doses given three weeks apart. It was given emergency use authorization by the World Health Organization in December.\nNo significant vaccine failure\nPfizer and BioNTech pointed to data fromIsrael’s health ministry that said there was decreased effectiveness in their vaccine,in terms of preventing infection and symptomatic disease.\nThe decline in efficacy coincided with the spread of the delta variant and the end of most Covid measures in Israel. The shot remains 93% effective in preventing hospitalizations and serious illness from Covid-19, the ministry reportedly said.\n\n The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose.Norman BaylorBIOLOGICS CONSULTING CEO\n\nBut Baylor, who is currently president and chief executive officer of Biologics Consulting, said close monitoring has not revealed “significant vaccine failures” so far.\n“We’re just not seeing that now,” he told“Street Signs Asia”on Thursday.\nCovid cases are rising in the U.S. again, butdoctors say the increase in cases and hospitalizations are due to the delta variant spreading in unvaccinated populations.\n“The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose,” Baylor said.\nHe said health agencies seem to be in agreement that a third dose is not needed.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nVaccine inequality\nRicher countries have been able to vaccinate large numbers of their population, while poorer countries lag behind.\nThe issue of vaccine disparity between regions needs to be addressed, Baylor said.\n“A pandemic itself, the definition is that it’s global,” he said, adding that he agrees with the World Health Organization that the crisis needs to be looked at from a global perspective.\n\n Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable.Tedros Adhanom GhebreyesusDIRECTOR-GENERAL, WORLD HEALTH ORGANIZATION\n\nWHO Director-General Tedros Adhanom Ghebreyesus said Monday thatthe world is “in the midst of a growing two-track pandemic.”\n“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable,”he said during a press briefing, adding that the world ismaking “conscious choices” not to protect those who are most in need.\nData suggests the vaccines offer long-lasting immunity against severe and deadly Covid-19, he said.\n“The priority now must be to vaccinate those who have received no doses and protection,” the WHO chief said.\nBiotech companies like Pfizer-BioNTech andModerna, which developed another mRNA vaccine for Covid-19, need to “go all out” to channel supplies to places in need, including through the Covax vaccine distribution alliance, he added.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5237288,"gmtCreate":1626416049887,"gmtModify":1635227980812,"authorId":3572489627147183,"author":{"id":3572489627147183,"idStr":"3572489627147183","authorId":3572489627147183,"name":"TeslaLegend","avatar":"https://static.tigerbbs.com/180ad6f06095bcbf2b6594d26c494752","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170144266,"type":1,"supId":0,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"},{"id":5247141,"gmtCreate":1626501667291,"gmtModify":1635227292266,"authorId":3575433293784452,"author":{"id":3575433293784452,"idStr":"3575433293784452","authorId":3575433293784452,"name":"erichosk","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170144266,"type":1,"supId":5237288,"prevId":0,"content":"<u>yup</u>","text":"<u>yup</u>","html":"<u>yup</u>"}],"langContent":"EN"},{"id":170140872,"gmtCreate":1626415179496,"gmtModify":1633926941012,"author":{"id":"3575164849845743","authorId":"3575164849845743","name":"Jiaenthebest","avatar":"https://static.tigerbbs.com/402c3f1c677491e2f9d432dc3958b8fb","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3575164849845743","authorIdStr":"3575164849845743"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/170140872","repostId":1176367685,"repostType":4,"repost":{"id":"1176367685","pubTimestamp":1626412781,"share":"https://www.laohu8.com/m/news/1176367685?lang=&edition=full","pubTime":"2021-07-16 13:19","market":"us","language":"en","title":"No evidence yet that it’s time for a 3rd booster, says former FDA director","url":"https://stock-news.laohu8.com/highlight/detail?id=1176367685","media":"cnbc","summary":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor","content":"<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>No evidence yet that it’s time for a 3rd booster, says former FDA director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNo evidence yet that it’s time for a 3rd booster, says former FDA director\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 13:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1176367685","content_text":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nPfizer said on July 8 that it is developing a Covid booster shot, or third dose, to target the highly transmissible delta variant.\n\nThere isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director.\n“Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review.\nPharmaceutical firm Pfizerisdeveloping a Covid booster shot, or third dose, to target the highly transmissible delta variant,which has become the dominant strain in many countries including the U.S.\nThe Centers for Disease Control and Prevention and FDA also said last week in a joint statement that“Americans who have been fully vaccinated won’t need a booster dose at this time.”\nPfizer met with U.S. officials on Mondayto make its case for a third shot.\nThe company worked with German companyBioNTechto develop a vaccine that consists of two doses given three weeks apart. It was given emergency use authorization by the World Health Organization in December.\nNo significant vaccine failure\nPfizer and BioNTech pointed to data fromIsrael’s health ministry that said there was decreased effectiveness in their vaccine,in terms of preventing infection and symptomatic disease.\nThe decline in efficacy coincided with the spread of the delta variant and the end of most Covid measures in Israel. The shot remains 93% effective in preventing hospitalizations and serious illness from Covid-19, the ministry reportedly said.\n\n The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose.Norman BaylorBIOLOGICS CONSULTING CEO\n\nBut Baylor, who is currently president and chief executive officer of Biologics Consulting, said close monitoring has not revealed “significant vaccine failures” so far.\n“We’re just not seeing that now,” he told“Street Signs Asia”on Thursday.\nCovid cases are rising in the U.S. again, butdoctors say the increase in cases and hospitalizations are due to the delta variant spreading in unvaccinated populations.\n“The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose,” Baylor said.\nHe said health agencies seem to be in agreement that a third dose is not needed.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nVaccine inequality\nRicher countries have been able to vaccinate large numbers of their population, while poorer countries lag behind.\nThe issue of vaccine disparity between regions needs to be addressed, Baylor said.\n“A pandemic itself, the definition is that it’s global,” he said, adding that he agrees with the World Health Organization that the crisis needs to be looked at from a global perspective.\n\n Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable.Tedros Adhanom GhebreyesusDIRECTOR-GENERAL, WORLD HEALTH ORGANIZATION\n\nWHO Director-General Tedros Adhanom Ghebreyesus said Monday thatthe world is “in the midst of a growing two-track pandemic.”\n“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable,”he said during a press briefing, adding that the world ismaking “conscious choices” not to protect those who are most in need.\nData suggests the vaccines offer long-lasting immunity against severe and deadly Covid-19, he said.\n“The priority now must be to vaccinate those who have received no doses and protection,” the WHO chief said.\nBiotech companies like Pfizer-BioNTech andModerna, which developed another mRNA vaccine for Covid-19, need to “go all out” to channel supplies to places in need, including through the Covax vaccine distribution alliance, he added.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5237211,"gmtCreate":1626415218639,"gmtModify":1635227985564,"authorId":3575164849845743,"author":{"id":3575164849845743,"idStr":"3575164849845743","authorId":3575164849845743,"name":"Jiaenthebest","avatar":"https://static.tigerbbs.com/402c3f1c677491e2f9d432dc3958b8fb","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170140872,"type":1,"supId":0,"prevId":0,"content":"Wow","text":"Wow","html":"Wow"}],"langContent":"EN"},{"id":170157552,"gmtCreate":1626415124576,"gmtModify":1631888657809,"author":{"id":"3555043402922696","authorId":"3555043402922696","name":"Never ever f","avatar":"https://static.tigerbbs.com/52501d43721648c944a019db9c767c5d","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3555043402922696","authorIdStr":"3555043402922696"},"htmlText":"Power booster&nbsp;","listText":"Power booster&nbsp;","text":"Power booster","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170157552","repostId":1176367685,"repostType":4,"repost":{"id":"1176367685","pubTimestamp":1626412781,"share":"https://www.laohu8.com/m/news/1176367685?lang=&edition=full","pubTime":"2021-07-16 13:19","market":"us","language":"en","title":"No evidence yet that it’s time for a 3rd booster, says former FDA director","url":"https://stock-news.laohu8.com/highlight/detail?id=1176367685","media":"cnbc","summary":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor","content":"<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>No evidence yet that it’s time for a 3rd booster, says former FDA director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNo evidence yet that it’s time for a 3rd booster, says former FDA director\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 13:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1176367685","content_text":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nPfizer said on July 8 that it is developing a Covid booster shot, or third dose, to target the highly transmissible delta variant.\n\nThere isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director.\n“Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review.\nPharmaceutical firm Pfizerisdeveloping a Covid booster shot, or third dose, to target the highly transmissible delta variant,which has become the dominant strain in many countries including the U.S.\nThe Centers for Disease Control and Prevention and FDA also said last week in a joint statement that“Americans who have been fully vaccinated won’t need a booster dose at this time.”\nPfizer met with U.S. officials on Mondayto make its case for a third shot.\nThe company worked with German companyBioNTechto develop a vaccine that consists of two doses given three weeks apart. It was given emergency use authorization by the World Health Organization in December.\nNo significant vaccine failure\nPfizer and BioNTech pointed to data fromIsrael’s health ministry that said there was decreased effectiveness in their vaccine,in terms of preventing infection and symptomatic disease.\nThe decline in efficacy coincided with the spread of the delta variant and the end of most Covid measures in Israel. The shot remains 93% effective in preventing hospitalizations and serious illness from Covid-19, the ministry reportedly said.\n\n The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose.Norman BaylorBIOLOGICS CONSULTING CEO\n\nBut Baylor, who is currently president and chief executive officer of Biologics Consulting, said close monitoring has not revealed “significant vaccine failures” so far.\n“We’re just not seeing that now,” he told“Street Signs Asia”on Thursday.\nCovid cases are rising in the U.S. again, butdoctors say the increase in cases and hospitalizations are due to the delta variant spreading in unvaccinated populations.\n“The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose,” Baylor said.\nHe said health agencies seem to be in agreement that a third dose is not needed.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nVaccine inequality\nRicher countries have been able to vaccinate large numbers of their population, while poorer countries lag behind.\nThe issue of vaccine disparity between regions needs to be addressed, Baylor said.\n“A pandemic itself, the definition is that it’s global,” he said, adding that he agrees with the World Health Organization that the crisis needs to be looked at from a global perspective.\n\n Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable.Tedros Adhanom GhebreyesusDIRECTOR-GENERAL, WORLD HEALTH ORGANIZATION\n\nWHO Director-General Tedros Adhanom Ghebreyesus said Monday thatthe world is “in the midst of a growing two-track pandemic.”\n“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable,”he said during a press briefing, adding that the world ismaking “conscious choices” not to protect those who are most in need.\nData suggests the vaccines offer long-lasting immunity against severe and deadly Covid-19, he said.\n“The priority now must be to vaccinate those who have received no doses and protection,” the WHO chief said.\nBiotech companies like Pfizer-BioNTech andModerna, which developed another mRNA vaccine for Covid-19, need to “go all out” to channel supplies to places in need, including through the Covax vaccine distribution alliance, he added.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":170161991,"gmtCreate":1626413108313,"gmtModify":1633926957450,"author":{"id":"3578469466929319","authorId":"3578469466929319","name":"Rdzx93","avatar":"https://static.tigerbbs.com/d3b31c3cf3d38ea17bdffcc25191af86","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578469466929319","authorIdStr":"3578469466929319"},"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/170161991","repostId":1176367685,"repostType":4,"repost":{"id":"1176367685","pubTimestamp":1626412781,"share":"https://www.laohu8.com/m/news/1176367685?lang=&edition=full","pubTime":"2021-07-16 13:19","market":"us","language":"en","title":"No evidence yet that it’s time for a 3rd booster, says former FDA director","url":"https://stock-news.laohu8.com/highlight/detail?id=1176367685","media":"cnbc","summary":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor","content":"<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>No evidence yet that it’s time for a 3rd booster, says former FDA director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNo evidence yet that it’s time for a 3rd booster, says former FDA director\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 13:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1176367685","content_text":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nPfizer said on July 8 that it is developing a Covid booster shot, or third dose, to target the highly transmissible delta variant.\n\nThere isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director.\n“Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review.\nPharmaceutical firm Pfizerisdeveloping a Covid booster shot, or third dose, to target the highly transmissible delta variant,which has become the dominant strain in many countries including the U.S.\nThe Centers for Disease Control and Prevention and FDA also said last week in a joint statement that“Americans who have been fully vaccinated won’t need a booster dose at this time.”\nPfizer met with U.S. officials on Mondayto make its case for a third shot.\nThe company worked with German companyBioNTechto develop a vaccine that consists of two doses given three weeks apart. It was given emergency use authorization by the World Health Organization in December.\nNo significant vaccine failure\nPfizer and BioNTech pointed to data fromIsrael’s health ministry that said there was decreased effectiveness in their vaccine,in terms of preventing infection and symptomatic disease.\nThe decline in efficacy coincided with the spread of the delta variant and the end of most Covid measures in Israel. The shot remains 93% effective in preventing hospitalizations and serious illness from Covid-19, the ministry reportedly said.\n\n The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose.Norman BaylorBIOLOGICS CONSULTING CEO\n\nBut Baylor, who is currently president and chief executive officer of Biologics Consulting, said close monitoring has not revealed “significant vaccine failures” so far.\n“We’re just not seeing that now,” he told“Street Signs Asia”on Thursday.\nCovid cases are rising in the U.S. again, butdoctors say the increase in cases and hospitalizations are due to the delta variant spreading in unvaccinated populations.\n“The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose,” Baylor said.\nHe said health agencies seem to be in agreement that a third dose is not needed.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nVaccine inequality\nRicher countries have been able to vaccinate large numbers of their population, while poorer countries lag behind.\nThe issue of vaccine disparity between regions needs to be addressed, Baylor said.\n“A pandemic itself, the definition is that it’s global,” he said, adding that he agrees with the World Health Organization that the crisis needs to be looked at from a global perspective.\n\n Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable.Tedros Adhanom GhebreyesusDIRECTOR-GENERAL, WORLD HEALTH ORGANIZATION\n\nWHO Director-General Tedros Adhanom Ghebreyesus said Monday thatthe world is “in the midst of a growing two-track pandemic.”\n“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable,”he said during a press briefing, adding that the world ismaking “conscious choices” not to protect those who are most in need.\nData suggests the vaccines offer long-lasting immunity against severe and deadly Covid-19, he said.\n“The priority now must be to vaccinate those who have received no doses and protection,” the WHO chief said.\nBiotech companies like Pfizer-BioNTech andModerna, which developed another mRNA vaccine for Covid-19, need to “go all out” to channel supplies to places in need, including through the Covax vaccine distribution alliance, he added.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5237003,"gmtCreate":1626413118526,"gmtModify":1635227998987,"authorId":3578469466929319,"author":{"id":3578469466929319,"idStr":"3578469466929319","authorId":3578469466929319,"name":"Rdzx93","avatar":"https://static.tigerbbs.com/d3b31c3cf3d38ea17bdffcc25191af86","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170161991,"type":1,"supId":0,"prevId":0,"content":"Like and comment","text":"Like and comment","html":"Like and comment"},{"id":5237004,"gmtCreate":1626413125547,"gmtModify":1635227998878,"authorId":3578469466929319,"author":{"id":3578469466929319,"idStr":"3578469466929319","authorId":3578469466929319,"name":"Rdzx93","avatar":"https://static.tigerbbs.com/d3b31c3cf3d38ea17bdffcc25191af86","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170161991,"type":1,"supId":5237003,"prevId":0,"content":"Like and comment","text":"Like and comment","html":"Like and comment"},{"id":5237006,"gmtCreate":1626413132229,"gmtModify":1635227998769,"authorId":3578469466929319,"author":{"id":3578469466929319,"idStr":"3578469466929319","authorId":3578469466929319,"name":"Rdzx93","avatar":"https://static.tigerbbs.com/d3b31c3cf3d38ea17bdffcc25191af86","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3578469466929319,"repliedAuthor":{"id":3578469466929319,"idStr":"3578469466929319","authorId":3578469466929319,"name":"Rdzx93","avatar":"https://static.tigerbbs.com/d3b31c3cf3d38ea17bdffcc25191af86","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":170161991,"type":1,"supId":5237003,"prevId":5237004,"content":"Like and comment","text":"Like and comment","html":"Like and comment"},{"id":5237075,"gmtCreate":1626413738206,"gmtModify":1635227994585,"authorId":3572676784796175,"author":{"id":3572676784796175,"idStr":"3572676784796175","authorId":3572676784796175,"name":"Buffet97","avatar":"https://static.tigerbbs.com/9bf8ad93a7362a593fae5bc069705f2f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170161991,"type":1,"supId":0,"prevId":0,"content":"CommeNt","text":"CommeNt","html":"CommeNt"},{"id":5237127,"gmtCreate":1626414170873,"gmtModify":1635227990913,"authorId":3581492615633503,"author":{"id":3581492615633503,"idStr":"3581492615633503","authorId":3581492615633503,"name":"Clarissathin","avatar":"https://static.tigerbbs.com/309113fc9682c18e42c44353655899de","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170161991,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"}],"langContent":"EN"},{"id":170163285,"gmtCreate":1626413053147,"gmtModify":1633926958043,"author":{"id":"3580699893311710","authorId":"3580699893311710","name":"Avester","avatar":"https://static.tigerbbs.com/fc17dd0c5da2587e7a887802bef82983","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3580699893311710","authorIdStr":"3580699893311710"},"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/170163285","repostId":1176367685,"repostType":4,"repost":{"id":"1176367685","pubTimestamp":1626412781,"share":"https://www.laohu8.com/m/news/1176367685?lang=&edition=full","pubTime":"2021-07-16 13:19","market":"us","language":"en","title":"No evidence yet that it’s time for a 3rd booster, says former FDA director","url":"https://stock-news.laohu8.com/highlight/detail?id=1176367685","media":"cnbc","summary":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor","content":"<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>No evidence yet that it’s time for a 3rd booster, says former FDA director</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNo evidence yet that it’s time for a 3rd booster, says former FDA director\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 13:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://www.cnbc.com/2021/07/16/not-prudent-to-deploy-vaccine-boosters-at-this-point-ex-fda-director.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1176367685","content_text":"KEY POINTS\n\nThere’s not enough evidence that booster vaccines are needed for now, said Norman Baylor, president and chief executive officer of Biologics Consulting.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nPfizer said on July 8 that it is developing a Covid booster shot, or third dose, to target the highly transmissible delta variant.\n\nThere isn’t enough evidence right now to show that booster shots for Covid vaccines are needed, according to a former FDA director.\n“Being prepared to make boosters is a good thing, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or we’re seeing waning in immunity, such that it’s time to deploy a booster,” said Norman Baylor, who was previously with the U.S. Food and Drug Administration’s office of vaccines research and review.\nPharmaceutical firm Pfizerisdeveloping a Covid booster shot, or third dose, to target the highly transmissible delta variant,which has become the dominant strain in many countries including the U.S.\nThe Centers for Disease Control and Prevention and FDA also said last week in a joint statement that“Americans who have been fully vaccinated won’t need a booster dose at this time.”\nPfizer met with U.S. officials on Mondayto make its case for a third shot.\nThe company worked with German companyBioNTechto develop a vaccine that consists of two doses given three weeks apart. It was given emergency use authorization by the World Health Organization in December.\nNo significant vaccine failure\nPfizer and BioNTech pointed to data fromIsrael’s health ministry that said there was decreased effectiveness in their vaccine,in terms of preventing infection and symptomatic disease.\nThe decline in efficacy coincided with the spread of the delta variant and the end of most Covid measures in Israel. The shot remains 93% effective in preventing hospitalizations and serious illness from Covid-19, the ministry reportedly said.\n\n The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose.Norman BaylorBIOLOGICS CONSULTING CEO\n\nBut Baylor, who is currently president and chief executive officer of Biologics Consulting, said close monitoring has not revealed “significant vaccine failures” so far.\n“We’re just not seeing that now,” he told“Street Signs Asia”on Thursday.\nCovid cases are rising in the U.S. again, butdoctors say the increase in cases and hospitalizations are due to the delta variant spreading in unvaccinated populations.\n“The vaccine failures are really low at this time for the current vaccines that have been deployed. So until that shifts, I don’t think it would be prudent to deploy a booster dose,” Baylor said.\nHe said health agencies seem to be in agreement that a third dose is not needed.\n“We’re just not there yet … we don’t have the evidence that it’s time for a booster,” he said, adding that in future, there could be new variants that render current vaccines ineffective or much less effective.\nVaccine inequality\nRicher countries have been able to vaccinate large numbers of their population, while poorer countries lag behind.\nThe issue of vaccine disparity between regions needs to be addressed, Baylor said.\n“A pandemic itself, the definition is that it’s global,” he said, adding that he agrees with the World Health Organization that the crisis needs to be looked at from a global perspective.\n\n Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable.Tedros Adhanom GhebreyesusDIRECTOR-GENERAL, WORLD HEALTH ORGANIZATION\n\nWHO Director-General Tedros Adhanom Ghebreyesus said Monday thatthe world is “in the midst of a growing two-track pandemic.”\n“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and most vulnerable,”he said during a press briefing, adding that the world ismaking “conscious choices” not to protect those who are most in need.\nData suggests the vaccines offer long-lasting immunity against severe and deadly Covid-19, he said.\n“The priority now must be to vaccinate those who have received no doses and protection,” the WHO chief said.\nBiotech companies like Pfizer-BioNTech andModerna, which developed another mRNA vaccine for Covid-19, need to “go all out” to channel supplies to places in need, including through the Covax vaccine distribution alliance, he added.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5885284,"gmtCreate":1631757319109,"gmtModify":1634797954891,"authorId":3581550090206949,"author":{"id":3581550090206949,"idStr":"3581550090206949","authorId":3581550090206949,"name":"Sallkwan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170163285,"type":1,"supId":0,"prevId":0,"content":"Great","text":"Great","html":"Great"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":86,"commentSize":9,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}